Increasing the dose of ASA from @ mg to @ mg daily or switching ASA @ mg to clopidogrel @ mg daily may reduce concentrations of some inflammatory markers ( in particular hsCRP , IL-@ and CD@L ) in T@DM patients with HPR treated previously with @ mg of ASA .